Examining Parkinson’s disease psychosis treatment outcomes in the real world: The insyte observational study
Objective: The INSYTE Study–seeks to gain a better understanding of the management of PDP. INSYTE will describe the relative safety and effectiveness of various antipsychotic…Evaluation of Parkinson’s Disease Psychosis Requires Structured Questioning of Patients and Caregivers
Objective: To determine the relationship between the patient and caregiver experience of the psychotic features of Parkinson's disease psychosis (PDP) reported to call center healthcare…Patient Experience of Parkinson’s Disease Psychosis Management
Objective: To understand the experience and management of Parkinson’s disease psychosis (PDP). Background: PDP is a troubling non-motor symptom of Parkinson’s disease. Clinical approaches to…Patterns of Long-Term Custodial Care in Parkinson Disease Psychosis
Objective: Parkinson Disease (PD) progression is frequently associated with development of psychosis (P), leading to significant morbidity, caregiver distress, and other consequences. Although PDP often…Highly-selective blockade of 5-HT2A receptors with EMD-281,014 reduces the severity of L-DOPA-induced psychosis and dyskinesia in the MPTP-lesioned marmoset model of Parkinson’s disease
Objective: To investigate the effect of the highly-selective serotonin 2A (5-HT2A) receptor EMD-281,014 on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced psychosis-like behaviours (PLBs) and dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned…Post-Deep Brain Stimulation Psychosis in Parkinson’s Disease: A Meta-analysis
Objective: This systematic review and meta-analysis was designed to evaluate risk factors and correlates of psychosis in PD after DBS surgery. Background: Deep brain stimulation…Parkinson’s Disease Psychosis Associated Comorbidities, and Mortality in the Medicare Population
Objective: To characterize patients with Parkinson’s disease psychosis (PDP) in the Medicare database, determine comorbidities associated with PDP, and evaluate mortality in PDP compared to…An extraordinary cause of psychosis: Anti-NMDA receptor encephalitis
Objective: Anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis is an autoimmune encephalitis affecting predominantly young females. Background: It is characterized with neuropsychiatric symptoms, including personality changes, psychosis, autonomic…Sleep Abnormalities in patients with Parkinson’s disease having REM sleep behaviour disorder with and without Psychosis
Objective: To study the polysomnographic changes in patients of Parkinson’s disease with or without psychosis and evaluate any microarchitecture and microarchitecture changes. Background: Parkinson’s disease…In vivo MRI signatures of hippocampal subfield pathology in patients with Parkinson’s disease and psychosis
Objective: To study the role of hippocampal subfield pathology in the genesis of psychotic symptoms in patients with Parkinson's disease (PD) by comparing the volumes…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Next Page »